| Website | profibrix.com |
| Category | BioTech |
| Phone | 31 71 518 1432 |
| info@profibrix.com | |
| Employees | |
| Founded | 2004 |
| Description | biotechnology company |
| TOTAL | $22M |
| VENTURE FUNDING TOTAL | $22M |
| Series B, 8/09 Gilde Healthcare Partners | $11.4M |
| Series B, 8/11 Gilde Healthcare Partners Index Ventures | $10.6M |
ProFibrix B.V., a biotech company, creates, develops, and markets products for the hemostasis and regenerative medicine markets. Its products include Fibrocaps, a dry powder topical hemostat and tissue sealant based on a mixture of fibrinogen and thrombin, which stops acute and severe bleeding during surgery or in connection with trauma injury. The company also provides a sterilized single-use delivery device to deliver Fibrocaps to the target tissue area without the need to manipulate the wound in a surgical environment. It offers its products based on human fibrinogen, a natural blood protein for haemostasis, blood clotting, and tissue repair and healing. ProFibrix B.V. was founded in 2004
